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Calcium signaling is essential for regulating many biological
processes. Endoplasmic reticulum inositol trisphosphate receptors (IP3Rs) and the mitochondrial Ca2+ uniporter (MCU)
are key proteins that regulate intracellular Ca2+ concentration.
Mitochondrial Ca2+ accumulation activates Ca2+-sensitive dehydrogenases of the tricarboxylic acid (TCA) cycle that maintain the biosynthetic and bioenergetic needs of both normal
and cancer cells. However, the interplay between calcium
signaling and metabolism is not well understood. In this study,
we used human cancer cell lines (HEK293 and HeLa) with
stable KOs of all three IP3R isoforms (triple KO [TKO]) or
MCU to examine metabolic and bioenergetic responses to the
chronic loss of cytosolic and/or mitochondrial Ca2+ signaling.
Our results show that TKO cells (exhibiting total loss of Ca2+
signaling) are viable, displaying a lower proliferation and oxygen consumption rate, with no signiﬁcant changes in ATP
levels, even when made to rely solely on the TCA cycle for
energy production. MCU KO cells also maintained normal
ATP levels but showed increased proliferation, oxygen consumption, and metabolism of both glucose and glutamine.
However, MCU KO cells were unable to maintain ATP levels
and died when relying solely on the TCA cycle for energy. We
conclude that constitutive Ca2+ signaling is dispensable for the
bioenergetic needs of both IP3R TKO and MCU KO human
cancer cells, likely because of adequate basal glycolytic and
TCA cycle ﬂux. However, in MCU KO cells, the higher energy
expenditure associated with increased proliferation and oxygen
consumption makes these cells more prone to bioenergetic
failure under conditions of metabolic stress.

Ca2+ signaling plays an important role in regulating many
diverse biological processes ranging from cell proliferation,
secretion, motility, metabolism, and cell death (1). A key
event that initiates Ca2+ signaling is the release of Ca2+ from
intracellular stores by the three isoforms of inositol
* For correspondence: Suresh K. Joseph, suresh.joseph@jefferson.edu.

trisphosphate receptor (IP3R) channels (2). The depletion of
internal Ca2+ stores secondarily stimulates Ca2+ entry via
Orai channels in the plasma membrane. Thus, loss of IP3Rmediated Ca2+ signaling would block both the intracellular
and extracellular components of agonist-mediated Ca2+
signaling. An increase of cytosolic Ca2+ in the environment of
the mitochondria facilitates Ca2+ uptake into the matrix by a
complex of inner membrane proteins of which the mitochondrial Ca2+ uniporter (MCU) is the pore-forming constituent (3). The elevations of Ca2+ in the cytosol and
mitochondrial compartments act on multiple effector proteins to alter cell function (1, 4). In the mitochondrial matrix,
Ca2+ stimulates the activity of three dehydrogenases of the
tricarboxylic acid (TCA) cycle (5), respiratory complexes (6),
and ATP synthase (7) to enhance ATP generation. Higher
matrix Ca2+ accumulation can open the permeability transition pore and cause cell death (8). Inactivating the function
of all three IP3R isoforms or MCU channels would therefore
be expected to have wide-ranging effects, including
compromising the metabolic and bioenergetic status of the
cells.
Global and conditional KO mouse models of individual IP3R
isoforms have provided valuable information on the role of
Ca2+ signaling in regulating organ function (9–14). However,
functional redundancy and postnatal mortality have complicated these studies (15–19). Few studies have examined the
effects of the conditional deletion of all three IP3R isoforms. In
hematopoietic cells, these investigations indicated a critical
role for Ca2+ in regulating early developmental checkpoints in
T and B lymphocytes (20, 21). In mouse embryonic stem cells,
the IP3R TKO cells showed enhanced differentiation into the
cardiomyocyte lineage and impaired differentiation into the
hematopoietic lineage (22). Inducible KOs of all IP3R isoforms
in mouse vascular endothelial cells (14) or smooth muscle cells
(13) have been shown to affect basal blood pressure and
vascular tone.
Studying the mechanisms of adaptation to a loss of Ca2+
signaling is much easier in cultured cell systems than in animal
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KO models. A widely used cell culture model is a chicken
DT40 cell line in which all three IP3R isoforms have been
disrupted (23). However, studies using DT40 cells have primarily focused on the structure, function, and regulation of
IP3Rs (24). A number of reports have noted that DT40 IP3R
TKO cells have a baseline increase in autophagy (25–27).
Cardenas et al. (27) proposed that the increased autophagy
compensated for the bioenergetic deﬁcit caused by the loss of
endoplasmic reticulum (ER)/mitochondrial Ca2+ signaling
required to maintain optimal operation of the TCA cycle.
Cardenas et al. (28, 29) have extended these studies to
compare the effects of acute inhibition of ER/mitochondrial
Ca2+ transfer in normal and cancer cells. They concluded that,
unlike normal cells, the stimulation of autophagy in cancer
cells is not sufﬁcient to compensate for the increased energy
demand of uncontrolled growth, with cell death resulting from
a “bioenergetic crisis” during mitosis. The advent of new
methods of gene disruption has enabled all three IP3R isoforms
to be deleted in human embryonic kidney 293 (HEK293)
(30, 31) and HeLa (32) human cancer cell lines. While these
KO cells have primarily been used as an expression system to
study the functional properties of IP3R mutants, they also offer
the opportunity to investigate the metabolic and bioenergetic
consequences of the chronic effects of a total loss of Ca2+
signaling. This is the primary objective of the present
investigation.
Many studies have examined the physiological consequences of disrupting mitochondrial Ca2+ signaling using
global and tissue-speciﬁc MCU KO mouse models. In most
cases, a relatively mild phenotype at baseline has been
observed in tissues, such as the heart (33), skeletal muscle (34),
exocrine pancreas (35), endocrine pancreas (36), brown adipose tissue (37), and photoreceptors (38) suggesting the existence of robust adaptive mechanisms that have yet to be fully
characterized, including upregulation of alternative mechanisms of mitochondrial Ca2+ transport. Where metabolic
changes have been investigated in MCU KOs, the results have
generally been tissue speciﬁc. For example, fatty acid oxidation
is increased in cardiac (39) and skeletal muscle (34), and
decreased in liver (40) and pulmonary macrophages (41).
Relatively few studies have examined the metabolic or bioenergetic consequences of knocking out MCU in cultured
cells. Using RNA interference, it was concluded that MCU was
dispensable for growth in a breast cancer cell line (42) but
stimulated the growth and metastasis of hepatocellular carcinoma (43) and colorectal cancer cells (44). Silencing of MCU
in mouse pancreatic β-cells suppressed the increase of ATP/
ADP induced by glucose (45). The absence of MCU in vascular
smooth muscle cells impaired mitochondrial fusion and entry
into the G1/S phase of the cell cycle (46). The conditional
deletion of MCU from mouse embryonic ﬁbroblasts (MEFs)
enhanced differentiation to myoﬁbroblasts by an epigenetic
mechanism that involves enhanced glycolysis and increased
accumulation of α-ketoglutarate (α-KG) (47). Overall, it is
clear that the metabolic phenotype of the MCU KO cells is
dependent on the cell type being investigated. To obtain a
clearer picture of the metabolic consequences of disrupting
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either ER or mitochondrial Ca2+, we have carried out the
present study in which IP3Rs or MCU have been knocked out
in the same human cancer cell lines. Our studies show that the
IP3R TKO cells have adapted to the total loss of Ca2+ signaling
with a lower proliferation and oxygen consumption rate
(OCR), but no signiﬁcant changes in adenine nucleotides, even
when artiﬁcially made to rely entirely on the TCA cycle for
their bioenergetic and biosynthetic needs. By contrast, the loss
of MCU is associated with an increased proliferation and OCR,
increased metabolism of glucose and glutamine, a higher level
of basal AMP-dependent kinase (AMPK), and bioenergetic
failure when made to rely solely on the TCA cycle. We
conclude that baseline rates of aerobic glycolysis and the TCA
cycle are sufﬁcient to make constitutive ER/mitochondrial
Ca2+ signaling dispensable for the growth and function of both
IP3R TKO and MCU KO cancer cells. However, in MCU KO
cells, the higher energy expenditure associated with increased
proliferation and oxygen consumption make these cells more
prone to bioenergetic failure under conditions of metabolic
stress.

Results
Cytosolic and mitochondrial Ca2+
We initially characterized cytosolic Ca2+ signals in the IP3R
and MCU KO HEK293 cell models incubated in the absence
of extracellular Ca2+. As expected, the loss of all three IP3R
isoforms prevented any cytosolic Ca2+ changes induced by
carbachol (Cch) stimulation of endogenous muscarinic receptors (Fig. 1, A and B). MCU deletion was carried out in the
variant HEK293T cell line (48), and these cells showed a
decreased Cch-mediated cytosolic Ca2+ signal when
compared with the appropriate control of WT HEK293T
cells. The cytosolic Ca2+ responses of WT HEK293 and
HEK293T cells were not signiﬁcantly different (Fig. 1A), and
this also proved to be the case for several other parameters
measured in this study. This includes cell growth (Fig. 2A),
glucose utilization (Fig. S1A), glutamine consumption
(Fig. S1B), total NAD+ and NADH (Fig. S1, C and D), lactate
accumulation (Fig. S1E), ATP levels (Fig. S1F), phosphorylated AMPK levels (Fig. S1G), and phosphorylated pyruvate
dehydrogenase (p-PDH) levels (Fig. S1H). Hence, only the
WT HEK293 cells are represented as controls in most of the
remaining ﬁgures.
The ability of mitochondria to sequester and release a
50 μM pulse of Ca2+ in saponin-permeabilized cell lines was
measured in Figure 1, C and D. Both WT and IP3R TKO cells
had comparable rates of mitochondrial uptake and (carbonylcyanide-4-(triﬂuoromethoxy)phenylhydrazone)
(FCCP)induced release compared with the negligible rates for both
processes seen in the MCU KO cells. The MCU KO–
permeabilized cells consistently showed an elevated steady
state [Ca2+] in the medium prior to Ca2+ pulse addition. This
may reﬂect the failure of the cells to sequester the endogenous contaminating Ca2+ into the mitochondria before the
initiation of the experiment. The mitochondrial Ca2+ content
in intact cells was estimated using the ratiometric, high-
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Figure 1. Measurements of cytosolic and mitochondrial Ca2+ content in WT, IP3R TKO, and MCU-KO HEK293T cells. A, cytosolic Ca2+ changes in
response to 25 μM Cch was measured in the absence of external Ca2+. The data shown are from a representative experiment and are the mean ± SEM of
four replicates for each cell type. B, the quantitation of the amplitude of the changes in cytosolic Ca2+. The data are the mean ± SEM of three independent
experiments, each carried out in triplicate; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, one-way ANOVA followed by multiple comparison analysis
using Dunnett’s test. C, cells were permeabilized with saponin, and the clearance of a 50 μM pulse of Ca2+ added at 18 s was measured as described in the
“Experimental procedures” section. A further addition of 1 μM FCCP was made at 100 s. C, from a representative experiment. D, a quantitation in which the
initial rate of Ca2+ uptake over a 20 s period was calculated as given in (B) (n = 6). E, representative trace of epiﬂuorescence single-cell recordings of GEMGECO emission ratio in WT HEK293 showing matrix Ca2+ ([Ca2+]Mt) in response to the removal/chelation of [Ca2+]Ext with EGTA (10 mM) and in response to
FCCP (5 μM) and oligomycin (1 μg/ml) was measured. The subsequent addition of ionomycin (10 μM) was used as a uniporter-independent positive control
for [Ca2+]Mt. F, the quantiﬁcation of [Ca2+]Mt in the presence and absence of EGTA as measured by GEM-GECO emission ratio in WT, TKO, and MCU-KO cells.
Box plots show mean, median, interquartile range, and outlier markers. ***p < 0.001, one-way ANOVA followed by multiple comparison analysis using
Dunnett’s test. G and H, simultaneous [Ca2+]Cyt (Cal520) (gray traces) and [Ca2+]Mt (GEM-GECO emission ratio) in response to addition of carbachol (CCh) and
ionomycin to WT (G) and MCU-KO (H) HEK cells. The sustained elevation of mitochondrial Ca2+ signal in (G) is probably because of the asynchronous
oscillations of [Ca2+]Cyt observed in single cells after the initial rise of Ca2+ (not shown). I, box plot quantiﬁcation of Δ[Ca2+]Mt from individual cell recordings
in (G) and (H). Responses are plotted as [Ca2+]Mt peak (0–150 s) − [Ca2+]Mt baseline for CCh simulation and [Ca2+]Mt peak t > 150 s − [Ca2+]Mt plateau at
t = 150 s for ionomycin. ****p < 0.0001 Wilcoxon signed-rank test. FCCP, (carbonylcyanide-4-(triﬂuoromethoxy)phenylhydrazone); HEK293T, human
embryonic kidney 293T cell line; IP3R, inositol trisphosphate receptor; MCU, mitochondrial Ca2+ uniporter; TKO, triple KO.

afﬁnity, genetically encoded, ﬂuorescent probe GEM-GECO
(Kd 340 nM; (49)). The baseline signal in all three cell
lines was not signiﬁcantly decreased by chelation of extracellular Ca2+ or by depolarization with FCCP/oligomycin,
indicating that there is very little Ca2+ in the mitochondria
under unstimulated conditions (Fig. 1, E and F). The
measured basal content was only marginally lower (20%) in
IP3R TKO and MCU KO cells (Fig. 1F). It should be noted
that a variable lowering of mitochondrial Ca2+ content has
been reported in mouse MCU KO models (50–53). The

ability of the probe to register increases in mitochondrial
Ca2+ was veriﬁed by measuring responses to ionomycin and
Cch (Fig. 1, E, G, and H). Parallel measurements of cytoplasmic and mitochondrial Ca2+ conﬁrmed that Cch-induced
increases in mitochondrial Ca2+ were suppressed in the MCU
KO cells (Fig. 1, G–I). Taken together, the results show that
IP3R TKO cells have lost agonist-mediated cytosolic
Ca2+ signaling but retain the ability to sequester mitochondrial Ca2+, whereas the MCU KO cells have retained cytosolic
Ca2+ signaling (albeit at a reduced level) but have lost
J. Biol. Chem. (2022) 298(1) 101436
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Figure 2. Growth, glycolysis, and pyridine nucleotide levels in WT, IP3R TKO, and MCU-KO HEK293T cells. A, growth curves of the indicated
HEK293 cell lines were measured. The data shown are the mean ± SEM of three experiments. B, the media from cells grown for 4 to 5 days were replaced
with DMEM containing 5 mM glucose instead of 25 mM glucose. Aliquots of the media sampled at the times indicated were assayed for glucose. The data
shown are the mean ± SEM of four experiments. C, cells were deproteinized in 0.6 M perchloric acid, and neutralized lysates were assayed for lactate. D, as in
(C), but pyruvate was measured. The cytosolic-free NAD+/NADH ratio was calculated from the lactate/pyruvate ratio (E). Total NAD+ (F) and NADH (G) were
measured by an enzymatic cycling procedure. The total NAD+/NADH ratio is quantitated in (H). For (C–H), the data are the mean ± SEM of three independent experiments, each carried out in triplicate; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, one-way ANOVA followed by multiple comparison
analysis using Dunnett’s test. DMEM, Dulbecco’s modiﬁed Eagle’s medium; HEK293T, human embryonic kidney 293T cell line; IP3R, inositol trisphosphate
receptor; MCU, mitochondrial Ca2+ uniporter; TKO, triple KO.

mitochondrial Ca2+ uptake. The impact of these Ca2+
signaling phenotypes on metabolism and bioenergetics is
investigated later.
Cell growth and glucose metabolism
A number of basic growth and metabolic parameters were
measured in the HEK293 cell lines (Fig. 2). In the Dulbecco’s
modiﬁed Eagle’s medium (DMEM) growth medium (containing glucose [25 mM], glutamine [5 mM], and pyruvate
[1 mM]), the IP3R TKO cells grew more slowly, and the MCU
KO cells grew more rapidly, than their corresponding WT
counterpart (Fig. 2A). The cells were entirely dependent on
glucose and glutamine as fuels, since the omission of either
substrate prevented growth in all the cell lines (not shown).
Glucose consumption was measured at a lower glucose concentration of 5 mM and found to be comparable between WT
and IP3R TKO cells (Fig. 2B). However, the MCU KO cells
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consumed glucose more rapidly (Fig. 2B). Both cellular lactate
(Fig. 2C) and pyruvate (Fig. 2D) showed increased levels in the
MCU KO cells. The assumption of near equilibrium of the
lactate dehydrogenase (LDH) reaction allows calculation of the
free cytosolic NAD+/NADH ratio from the pyruvate/lactate
ratio (54). This calculation indicated a substantial increase in
the NAD+/NADH ratio in MCU KO cells (Fig. 2E). To verify
these ﬁndings, the total cellular levels of NAD+ and NADH
were also measured directly by an enzymatic cycling method
(Fig. 2, F and G). Signiﬁcant changes in NAD+ levels were not
observed, but the levels of NADH decreased substantially in
MCU KO cells and to a lesser extent in IP3R TKO cells
(Fig. 2G). Similar changes were also observed for NADP+/
NADPH (Fig. S2A). Quantitation of the total levels of metabolites by mass spectroscopy showed that MCU KO cells
have increased levels of glutamate, α-KG, and citrate
(Fig. S2B). These metabolite changes are consistent with
increased metabolism of glutamine in MCU KO cells. Similar
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increases in α-KG have been noted in MCU KO ﬁbroblasts
(47) and photoreceptors (38). In ﬁbroblasts, the increase in αKG was attributed to enhanced glutamine metabolism and
linked to epigenetic changes altering the methylation of histones. In photoreceptors, enhanced glutamine metabolism was
not observed. Both malate and aspartate levels were decreased
in the MCU KO HEK cells (Fig. S2B). The fall in aspartate
could in part be related to increased utilization, since large
increases were observed in carbamoyl aspartate (used in pyrimidine synthesis) and asparagine levels. The fall in malate is
expected, since malate is in equilibrium with aspartate through
oxaloacetate. The fall in these metabolites may disrupt the
malate/aspartate shuttle and may account for the increased
reliance on lactate production as a means of regenerating the

NAD+ required for glycolysis. Overall, these results indicate
that there are marked increases in growth rate, glycolysis, and
NAD+/NADH redox state in the MCU KO cells.
Key bioenergetic parameters in WT, IP3R TKO, and MCU KO
cells
Altered supply of NADH by dehydrogenases and/or utilization by the respiratory chain may underlie the observed
changes in NAD+/NADH ratio. This prompted us to examine
the OCR of the KO cell lines (Fig. 3, A and B). In intact cells
exposed to complete growth medium, the basal OCR of MCU
KO cells was increased by 60% relative to WT cells. Under
the same conditions, the OCR of IP3R TKO cells was

Figure 3. Some bioenergetic parameters of HEK293 KO cells. A, equal amounts of cells (106) incubated in complete DMEM were added to the chamber
of an O2 electrode, and rates of O2 consumption (OCR) were measured under basal conditions and after the sequential additions of oligomycin (1 μg/ml),
FCCP (1 μM), and antimycin A (2 μM). B, quantiﬁcation of OCR is shown normalized to the basal OCR of WT cells. The data are the mean + SEM of three
independent experiments, each carried out in triplicate: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, two-way ANOVA followed by multiple
comparison analysis using Dunnett’s test. C, ATP was measured in neutralized perchloric acid (PCA) lysates with a luciferase assay. D, AMP was measured in
lysates processed for LC–MS/MS experiments. E and F, the phosphorylation status of AMPK and PDH measured by immunoblotting with phospho-speciﬁc
antibodies. Values are normalized to the total levels of the enzymes. Statistical evaluation for (C–F) used one-way ANOVA with symbols as in (B). AMPK, AMPdependent kinase; DMEM, Dulbecco’s modiﬁed Eagle’s medium; FCCP, (carbonylcyanide-4-(triﬂuoromethoxy)phenylhydrazone); HEK293, human embryonic
kidney 293T cell line; OCR, oxygen consumption rate; PDH, pyruvate dehydrogenase.
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decreased by 25%. The same trends were observed when
respiration was uncoupled with FCCP. Differences in OCR in
intact cells could reﬂect altered availability of substrates to the
respiratory chain. However, the decreased OCR in IP3R TKO
cells and increased OCR in MCU KO cells was also observed
in permeabilized cells supplied with an excess of glutamate/
malate and ADP (Fig. S2C). In the case of MCU KO cells,
differences of OCR seen in intact cells in the presence of oligomycin or FCCP were not observed in permeabilized cells,
suggesting that the differences seen in intact cells under these
conditions may reﬂect enhanced substrate availability. We
examined the ability of the cell lines to maintain basal ATP
levels and found no statistical differences between the three
cell lines (Fig. 3C). However, the basal AMP levels were substantially elevated in the MCU KO cells and to a smaller extent
in IP3R TKO cells (Fig. 3D). The different AMP levels correlated with the phosphorylation state of AMPK in the three cell
lines (Fig. 3E). PDH is a key mitochondrial phosphoenzyme
controlling the ﬂow of glucose carbon into the TCA cycle and
would therefore be one of many steps controlling NADH
supply. The dephosphorylation and activation of PDH is
catalyzed by a Ca2+-sensitive phosphatase (5). In agreement
with other MCU KO models (34, 50, 55, 56), the phosphorylation of PDH is substantially increased in MCU KO HEK293T

cells. However, PDH phosphorylation was unaltered in IP3R
TKO cells (Fig. 3F).
Autophagy is a key cellular process regulated by the energy
sensor AMPK (57). We therefore measured autophagy in the
three cell lines by quantitating microtubule-associated protein
1 light chain 3 (LC3) conversion and p62 degradation detected
by immunoblotting (Fig. 4). The data show increased levels of
LC3-II (Fig. 4, A and B) and p62 (Fig. 4, C and D) in the IP3R
TKO cells but not in MCU KO cells. In order to distinguish
between effects on enhanced autophagosome formation or
decreased fusion with lysosomes, we blocked the latter process
by preincubation of the cells with baﬁlomycin (58). The increase in LC3-II/p62 observed in IP3R TKO cells was retained
in the baﬁlomycin-treated cells with no additional changes
seen in the MCU KO cells. The results are in line with several
studies showing enhanced autophagy in IP3R TKO DT40
lymphocytes that is AMPK independent ((25, 26); but see
Ref. (27)). The data also show that the AMPK activation seen
in MCU KO cells does not lead to enhanced autophagy.
Isotope tracer analysis
To investigate the metabolism of glucose in more detail, we
used U–13C-glucose and mass spectroscopy. For the isotope

Figure 4. Autophagy is enhanced in IP3R KO cells but not in MCU KO cells. A, cells grown for 4 to 5 days in nutrient-replete medium were analyzed by
immunoblotting for LC3 in the presence or the absence of baﬁlomycin treatment (10 nM; 2 h). Quantitation of the LC3-II band is shown in B with data
expressed relative to WT, untreated cells. C, lysates were immunoblotted for p62, and the data are quantitated in (D) with data expressed relative to WT,
untreated cells. For (B) and (D), each point is an independent experiment performed in duplicate, error bars represent SEM, n = 5; *p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001, two-way ANOVA followed by multiple comparison analysis using Dunnett’s test. The data indicated no statistically signiﬁcant
interaction between the effects of cell lines and baﬁlomycin for either LC3 (F(2,4) = 0.117, p = 0.89) or p62 (F(2,24) = 4.25, p = 0.0263). IP3R, inositol trisphosphate receptor; LC3, microtubule-associated protein light chain 3; MCU, mitochondrial Ca2+ uniporter.
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Figure 5. [U–13C]-glucose tracer analysis in WT, IP3R TKO, and MCU KO cells. Cells were incubated in glucose-free DMEM for 30 min, and then, the
medium was replaced with DMEM containing 5 mM uniformly labeled 13C-glucose for 5 or 60 min. Samples were prepared for LC–MS as described in the
“Experimental procedures” section. Only the 60 min data for selected metabolites are shown in (A–F). Data are the fractional enrichment of the indicated
isotopolog given as the mean ± SEM of three separate plates for each condition. A simpliﬁed cartoon of the ﬂow of labeled carbon (shaded gray) is shown
with steps involving multiple enzymes being indicated by dotted arrows. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, one-way ANOVA followed by
multiple comparison analysis using Dunnett’s test. DMEM, Dulbecco’s modiﬁed Eagle’s medium; IP3R, inositol trisphosphate receptor; MCU, mitochondrial
Ca2+ uniporter; TKO, triple KO.

tracer experiments, the glucose in DMEM was reduced to
5 mM for 30 min and then switched to 5 mM U–13C-glucose
for 5 and 60 min. We found the labeling of glycolytic intermediates to be the same at both time points, and therefore,
only the 60 min data are shown (Fig. 5). The rapid labeling
kinetics precluded any conclusions regarding differences in
glycolytic rates based on U–13C-glucose experiments. The
fractional enrichment (FE) of m + 5 ribose-5-phosphate was
decreased in MCU KO cells suggesting that less glucose carbon may be diverted into the pentose phosphate shunt in these
cells (Fig. 5A). This would be compatible with the measured
increase in the NADP/NADPH ratio (Fig. S2A). The ﬂow of
glucose carbon into the TCA cycle was signiﬁcantly slower
than the labeling of glycolytic intermediates since negligible
labeling of TCA cycle intermediates was observed at 5 min
(not shown). Despite our observations on the differences in

phosphorylation state of PDH, the incorporation of two carbon
units into citrate via PDH was not signiﬁcantly different in the
three cell lines (Fig. 5B). Whereas FE of m + 2 citrate reached
40%, the FE of m + 2 in α-KG (Fig. 5C), malate (Fig. 5D), or
aspartate (a surrogate for labeling in oxaloacetate; Fig. 5E) was
much lower in all three cell lines (3–15%). In part, this
discrepancy could arise if substantial amounts of citrate are
exported from the mitochondria to the cytosol for utilization
in the ATP citrate lyase reaction that supplies acetyl CoA for
lipid biosynthesis. The formation of m + 2 TCA metabolites
was highest in the MCU KO cells (FE, 12–15%) indicating
increased forward ﬂux in the TCA cycle, which includes the
segments containing Ca2+-sensitive isocitrate and α-KG
dehydrogenases.
The removal of TCA cycle intermediates for biosynthetic
reactions necessitates anaplerotic pathways to replenish these
J. Biol. Chem. (2022) 298(1) 101436
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molecules. A major anaplerotic reaction involving glucose
metabolism is the formation of oxaloacetate from pyruvate by
the pyruvate carboxylase (PC) enzyme. This step acting on
m + 3 pyruvate would generate m + 3 oxaloacetate which, in
addition to being in equilibrium with m + 3 malate (Fig. 5D)
and aspartate (Fig. 5E), can also generate m + 3 citrate
(Fig. 5B). The formation of m + 3 citrate has been used to
monitor PC ﬂux in U–13C-glucose tracing experiments (59). In
WT cells, PC ﬂux was small (FE, 3%) relative to the ﬂux of
carbon through PDH (FE, 40%) (Fig. 5B). However, PC ﬂux
was selectively stimulated by 70% in MCU KO cells (Fig. 5B).

Glutamine is a major substrate feeding carbon into the TCA
cycle that can potentially supply both energy and biosynthetic
intermediates (60). We therefore analyzed U–13C-glutamine
metabolism in the three cell lines using time points of 30 min
and 1 h. The sum of label accumulating in several glutamine
metabolites (glutamate, α-KG, aspartate, citrate/isocitrate, and
cis-aconitate) was taken as a measure of overall glutamine
metabolism. This was found to be substantially increased in
the MCU KO cells with a much smaller (but signiﬁcant) increase also noted in the IP3R 3KO cells (Fig. 6A). Metabolism
of U–13C-glutamine by the combined actions of glutaminase,

Figure 6. [U–13C]-glutamine tracer analysis WT, IP3R TKO, and MCU KO cells. Cells were washed in glutamine-free DMEM and then incubated in a
DMEM containing 5 mM uniformly labeled 13C-glutamine for 30 or 60 min. Samples were prepared for LC–MS/MS as described in the “Experimental
procedures” section. A, the sum of counts appearing as glutamate, α-ketoglutarate, aspartate, citrate/isocitrate, and cis-aconitate was taken as a measure of glutamine metabolism. The data were normalized to protein. The error bars were smaller than symbol size. Only the 60 min data for selected
metabolites are shown in (B–H). Data are the fractional enrichment of the indicated isotopolog given as the mean ± SEM of three separate plates for each
condition. A simpliﬁed cartoon of the ﬂow of labeled carbon (shaded gray) is shown with steps involving multiple enzymes being indicated by dotted arrows.
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, one-way ANOVA followed by multiple comparison analysis using Dunnett’s test. DMEM, Dulbecco’s
modiﬁed Eagle’s medium; IP3R, inositol trisphosphate receptor; MCU, mitochondrial Ca2+ uniporter; TKO, triple KO.
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glutamate dehydrogenase, and glutamate transaminases would
generate m + 5 labeled α-KG. The “forward” direction of the
TCA cycle would generate m + 4 oxaloacetate, and condensation with unlabeled acetyl-CoA would produce m + 4 citrate.
Any limitation in the supply of acetyl-CoA as a result of a
block at PDH should lower labeling of m + 4 citrate, but this
was not observed for either of the KO cell lines (Fig. 6B).
Indeed, a small increase was seen in the MCU KO cells. The
same pattern of changes was also seen for m + 4 labeled malate
(Fig. 6F), indicating no suppression of ﬂux at the Ca2+-sensitive
α-KG dehydrogenase step. As observed in the glucose labeling
data, the oxidative ﬂux through the citrate/α-KG span is
increased in the MCU KO cells (Fig. 6E). Carbon entering the
TCA cycle as α-KG can also proceed in the “reverse” direction
as a result of reductive carboxylation (RC) to generate m + 5
labeled isocitrate, which is in equilibrium with citrate (Fig. 6C).
This reverse ﬂux in WT cells was 20% of the oxidative ﬂux as
judged by the relative FEs of m + 4 and m + 5 citrates (Fig. 6, B
and C). In IP3R TKO cells, this ratio of ﬂuxes was increased to
30%. In MCU KO cells, there was a twofold increase in RC
ﬂux, but since the oxidative ﬂux was also increased, the overall

partitioning of the two pathways was also 30%. There is
evidence that RC of glutamine can supply acetyl-CoA for fatty
acid biosynthesis via mitochondrial citrate export and cleavage
by the ATP–citrate lyase reaction (61–63). This reaction acting
on m + 5 citrate would generate m + 3 malate (a proxy for
m + 3 oxaloacetate). Indeed, the labeling of m + 3 malate in the
three cell lines follows the same pattern as m + 5 citrate
(Fig. 6G). MCU KO cells showed a signiﬁcantly increased labeling of m + 2 palmitic acid by acetyl-CoA derived from
glutamine metabolism (Fig. 6H).

KO HeLa cells and MCU rescue of HEK293T cells
To determine if the observed phenotypes of the IP3R TKO
and MCU KO are unique to HEK293 cell lines, we examined
the effects of these KOs in the HeLa cell line. The IP3R TKO
HeLa cells have been used previously and shown to
completely lack histamine-induced cytosolic Ca2+ transients
(32). CRISPR-mediated gene targeting was used to produce
the MCU KO HeLa cells (Fig. 7A). Loss of MCU function in
the KO cells was conﬁrmed by the lack of uptake of a pulse of

Figure 7. Characteristics of HeLa cells with IP3R and MCU KOs and MCU-rescued HEK293T MCU KO cells. A, MCU immunoblotting conﬁrmed loss of
MCU in two of four HeLa clones after CRISPR KO. HEK293T WT and MCU-KO cells were used as positive and negative controls, respectively. GAPDH was the
loading control. B, cells were permeabilized with saponin, and the clearance of a 50 μM pulse of Ca2+ added at 18 s was measured using Fluo-5 as described
in the “Experimental procedures” section. A further addition of 1 μM FCCP was made as shown. C, HeLa cells were loaded with Fluo-8 AM as described in the
“Experimental procedures” section, and changes to cytosolic Ca2+ in response to increasing doses of histamine were measured. D, neutralized PCA lysates of
HeLa cells were assayed for lactate. Data are the mean ± SEM, n = 3; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, one-way ANOVA followed by
multiple comparison analysis using Dunnett’s test. E and F, phosphorylation status of HeLa PDH and AMPK was measured by immunoblotting. Values are
normalized to the total levels of each protein with each point representing the mean of an independent experiment performed in duplicate. G, growth
curves for WT, TKO, and MCU-KO HeLa cell lines. Mean ± SEM (n = 3). H, immunoblot for MCU and Flag in MCU-rescue in HEK293T clones. GAPDH was used
as a loading control. The lower two panels show phosphorylated and total levels of AMPK. I, Ca2+ clearance in permeabilized HEK293T cells was measured as
in (B). J, intact HEK293T cells were loaded with Fura-2 as described in the “Experimental procedures” section, and cytosolic Ca2+ changes in response to
25 μM carbachol was measured. K, lactate in HEK293T cells was measured in triplicate for three independent experiments as in (D). Statistical evaluation of
data in (E–G) and (K) was as in (D). AMPK, AMP-dependent kinase; FCCP, (carbonylcyanide-4-(triﬂuoromethoxy)phenylhydrazone); HEK293T, human embryonic kidney 293T cell line; IP3R, inositol trisphosphate receptor; MCU, mitochondrial Ca2+ uniporter; PCA, perchloric acid; PDH, pyruvate dehydrogenase.
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Ca2+ delivered to permeabilized HeLa cells (Fig. 7B). As noted
previously (Fig. 1A), the MCU KO HEK293T cells display a
smaller cytosolic Ca2+ response to a saturating dose of Cch.
The MCU KO HeLa cells also gave a reduced response to
histamine (Fig. 7C) when compared with WT HeLa cells, but
the differences were smaller than noted in HEK293 cells. As
observed in HEK293T cells, lactate levels were also elevated
in MCU KO HeLa cells and were unchanged in IP3R TKO
cells (Fig. 7D). The smaller effects in HeLa cells may be
related to their lesser reliance on glycolysis for ATP production than HEK293 cells (64, 65). The phosphorylation
state of PDH (Fig. 7E), AMPK (Fig. 7F), as well as the growth
rates of the different HeLa cell lines (Fig. 7G) were all qualitatively similar to the changes observed for the HEK293 cell
lines. These data indicate that the observed phenotypes of
MCU KO and IP3R TKO cells are not unique to the
HEK293 cell line.
Another concern of using KO cells is the possibility that the
observed phenotypes are due to off-target effects of the
knockdown methodology. To determine if this may be the case
in the MCU KO HEK293T cells, we sought to determine if
stably reintroducing the MCU reverted some of the observed
changes. The rescued expression of MCU was conﬁrmed by
immunoblotting (Fig. 7H). The restoration of mitochondrial
Ca2+ uptake could be demonstrated in Ca2+ clearance assays
using permeabilized cells (Fig. 7I). In intact cells, the Cchinduced cytosolic Ca2+ increase was enhanced in the MCUrescue cells when compared with the MCU KO cells and
was approximately 85% of WT cells (Fig. 7J). The increased
lactate levels (Fig. 7K) and increased AMPK phosphorylation
(Fig. 7H, lower two panels) observed in MCU KO cells were
also diminished toward levels observed in WT cells. We
conclude that, at least for the parameters measured, the
observed phenotype of MCU KO cells is unlikely to be due to
off-target effects.
Forced utilization of the TCA cycle for energy production in
the three cell lines
Constitutive Ca2+-stimulated mitochondrial oxidative
metabolism has been proposed to be particularly important
for maintaining the bioenergetics requirements of cancer
cells (27, 28). This hypothesis is difﬁcult to test in our KO
models because HEK293 cells rely almost entirely on
glycolysis to support their energy requirements (66, 67).
Galactose metabolism minimizes the energy yield from
glycolysis and makes cells increasingly reliant on the TCA
cycle and oxidative phosphorylation to supply their energy
needs (68). We therefore removed the glucose in DMEM and
replaced it with 10 mM galactose. Oligomycin treatment of
WT, IP3R TKO, or MCU KO cells grown in glucosecontaining medium had negligible effects on ATP levels, as
expected if oxidative phosphorylation makes a minimal
contribution to ATP production (Fig. 8A). By contrast,
blocking glycolysis with iodoacetate lowered ATP levels in
all three cell lines. Oligomycin markedly reduced ATP levels
in all three cell lines incubated in galactose medium,
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indicating the dominant role of oxidative phosphorylation
under these conditions. The ability of the cell lines to
maintain their levels of ATP and AMP was followed for
different periods after the galactose switch. Over a period of
2 h, the cells had no difﬁculty in maintaining their ATP and
AMP (Fig. 8, B and C). However, more prolonged incubation
in galactose led to a progressive decrease in ATP and
elevation of AMP in the MCU KO cells but not in the WT or
IP3R TKO cell lines. When cytotoxicity was measured with a
ﬂuorescent dye assay, it was evident that the MCU KO
showed evidence of cell death that was signiﬁcant at 18 h and
markedly pronounced at 24 h after galactose incubation
(Fig. 8D). There was no evidence of signiﬁcant cytotoxicity in
the WT or IP3R TKO cell lines after prolonged incubation in
galactose medium. Interestingly, the cytotoxicity observed in
the MCU KO cells was strongly suppressed in the MCUrescue cell line.

Discussion
The KO cell models used in this study were intended to
compare the chronic metabolic and bioenergetic changes
resulting from the loss of either cytosolic Ca2+ signaling (IP3R
TKO) and/or mitochondrial Ca2+ signaling (MCU KO and
IP3R TKO). The changes we measured are summarized in the
scheme shown in Figure 9. The most prominent changes
observed in the MCU KO HEK293T cells were increased
glycolysis, glutamine metabolism, and increased growth rate.
Presumably, the enhanced consumption of fuels and the
increased oxygen consumption of MCU KO cell are needed to
meet the demands of increased growth. Varied results have
been reported when examining the effects of MCU loss on
growth. Although we found an increased growth rate of MCU
KO HEK293T and HeLa cells, Hall et al. (42) found HeLa cell
proliferation to be decreased not only when MCU levels were
diminished with siRNA but also when MCU activity was
increased with MICU1 siRNA. Growth was diminished in
MCU KO MEFs (47) but unaltered in siRNA-treated MD-MB231 breast carcinoma cells (42). In agreement with our ﬁndings, knockdown of MCU in primary B lymphocytes enhanced
proliferation in response to anti-immunoglobulin M (69).
A stimulation of glycolysis has been noted in several mouse
models of MCU KO (34, 55) and MCU KO MEFs (47). The
usual explanation offered for this effect is that loss of mitochondrial Ca2+ increases the phosphorylation state of PDH,
and therefore diminishes its activity, which diverts pyruvate
into lactate formation instead of entry into the TCA cycle.
Although there are exceptions (39, 53), the loss of MCU is
consistently associated with increased p-PDH (34, 50, 55, 56),
as also seen in our MCU KO cells (Figs. 3F and 7F). However,
there are several reasons for believing that lowered mitochondrial Ca2+ and p-PDH changes are not the underlying
reason for the increased glycolysis. First, the mitochondrial
Ca2+ content of WT and KO cells is already very low and can
be estimated to be much lower than the Kd of the GEM-GECO
probe (i.e., <300 nM). Since the K0.5 for PDH activation by
Ca2+ in isolated mitochondria is in the range of 300 to 500 nM
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Figure 8. Forced utilization of the TCA cycle in HEK293 cells. A, 1.0 × 105 cells were seeded on 60 mm plates and grown for 72 h in glucose containing
DMEM. Media were aspirated and replaced with glucose-free DMEM containing 10 mM galactose. Cells were treated with either 1 μM iodoacetate (IAA) or
5 μM oligomycin. After 1 h, cells were deproteinized in 0.6 M perchloric acid, neutralized, and ATP was measured with a luciferase assay. B–D, ATP, AMP, and
cytotoxicity were measured at various time points following glucose removal and galactose addition. Values shown are the mean ± SEM of three
experiments. B, ATP was measured in neutralized PCA lysates using a luciferase assay. C, AMP was measured in neutralized PCA lysates using a Promega
AMP-Glo assay. D, cell death was measured in real time using a Promega CellTox Green cytotoxicity assay, n = 3; *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001, two-way ANOVA followed by multiple comparison analysis using Dunnett’s test. The data indicated a statistically signiﬁcant interaction
between the effects of cell lines and galactose (F(28, 264) = 39.24, p < 0.0001). DMEM, Dulbecco’s modiﬁed Eagle’s medium; HEK293, human embryonic
kidney 293 cell line; PCA, perchloric acid; TCA, tricarboxylic acid.

(70), the small changes in baseline Ca2+ content are unlikely to
have a major impact on levels of p-PDH. Second, only the
MCU KO cells show substantially increased PDH phosphorylation, although both MCU KO and IP3R TKO cells have
comparable mitochondrial Ca2+ signals. Previous studies in
intact mitochondria have shown that the stimulatory effects of
Ca2+ on PDH phosphatase are more evident when the activity
of PDH kinase is partially inhibited (71). Pyruvate and NADH
are both regulators of PDH kinase and their changes in MCU
KO cells are in the direction that would act to partially inhibit
PDH kinase (72). Since these metabolites do not change in
IP3R TKO cells, it is possible that the sensitivity of PDH has
shifted to a lower range of mitochondrial Ca2+ content in
MCU KO cells. Finally, the direct measurement of isotope
tracer ﬂux of [U–13C] glucose carbon into m + 2 citrate
showed no signiﬁcant differences between the cell lines, indicating that the ﬂow of carbon into the TCA cycle was not
diminished despite increased p-PDH. A similar ﬁnding was
made in a mouse heart MCU KO model using NMR to study
the metabolism of [1,2-13C] glucose (73). The increased levels
of the PDH substrate pyruvate in the MCU KO cells probably

contributes to the maintenance of PDH ﬂux, despite enhanced
PDH phosphorylation. If PDH ﬂux is not the critical factor
then what else could account for enhanced glycolysis in MCU
KO cells? Flux through glycolysis is affected by multiple regulatory mechanisms, but one key factor is the cytosolic NAD+/
NADH ratio, which modulates the activity of glyceraldehyde 3phosphate dehydrogenase. A continuous supply of NAD+ to
this enzyme is maintained by NADH utilization by the NADH
oxidases of the respiratory chain and enzymes such as LDH
and malate dehydrogenase in the cytosol. MCU KO cells have
an increased NAD+/NADH ratio that is mainly because of a
fall in NADH levels (Fig. 2). Both basal respiration and lactate
formation are increased in MCU KO cells. Elevated NAD+/
NADH ratios with decreased NADH levels has been shown to
enhance glycolytic rate in several experimental systems
(74–77). An additional factor that may contribute to enhanced
glycolysis in MCU KO cells is the activation of AMPK
(Fig. 3E), which is known to phosphorylate and stimulate
phosphofructokinase-2 (78).
Maintaining the higher growth rate of MCU KO cells requires an increased supply of both energy and biosynthetic
J. Biol. Chem. (2022) 298(1) 101436
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Figure 9. Schematic summarizing some of the pathways altered by the chronic loss of IP3Rs and MCU. The acute responses to loss of
ER–mitochondrial Ca2+ transport in cancer cells as documented in the literature (29, 30, 94) are shown above the dotted line. The adaptive chronic changes
measured in the present study are shown below the dotted line. Upregulated or downregulated parameters are indicated by arrows colored red for IP3R TKO
and blue for MCU KO. The absence of an arrow indicates no change or minimal change in that parameter. Unlike acute effects, the chronic loss of
ER–mitochondrial Ca2+ signaling maintains ATP levels and avoids bioenergetic failure. ER, endoplasmic reticulum; IP3R, inositol trisphosphate receptor;
MCU, mitochondrial Ca2+ uniporter.

building blocks. It is well established that glutamine metabolism contributes to both functions (79), and enhanced
glutamine metabolism often accompanies increased aerobic
glycolysis in cancer cells (60). Stimulated glutamine metabolism has been reported in MCU KO ﬁbroblasts (47). Our
experiments with [U–13C] glutamine show that MCU KO
HEK293T cells have an increased ﬂow of glutamine carbon
into the TCA cycle, and the metabolism of α-KG is enhanced
in both the oxidative and reductive directions (Fig. 6). The
increased ﬂux in the oxidative direction occurs independently
of any increase in mitochondrial Ca2+ and may be related to
the increased citrate (Fig. S2B) and lowered NAD(P)H
(Figs. 2G and S2A), both of which are allosteric modiﬁers of
mitochondrial isocitrate dehydrogenase-3. Increased ﬂux of αKG in the oxidative pathway is also required to supply the
reducing equivalents required for RC (80). RC is commonly
observed in the absence of an adequate supply of acetyl-CoA
from PDH, as seen, for example, in hypoxia (81). Since PDH
ﬂux is not altered in MCU KO cells, the stimulated RC is more
likely to be secondary to increased α-KG availability provided
by enhanced glutamine metabolism. Interestingly, increased
RC also accompanies stimulated glycolysis (82, 83) or high
extracellular lactate (84). Both these conditions prevail in
MCU KO cells. A further important conclusion from the
13
C-tracer studies is the lack of suppression of basal ﬂux
through any of the three Ca2+-sensitive TCA cycle dehydrogenases when MCU or IP3Rs are deleted, implying that
any small decreases in basal mitochondrial [Ca2+] occurring in
the KO cells are not sufﬁcient to impact ﬂux through these
enzymes. This conclusion contrasts with the recent ﬁndings of
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Cardenas et al. (29) that constitutive Ca2+ regulation of α-KG
dehydrogenase is required to maintain RC in a mutant osteosarcoma cell line with defective oxidative phosphorylation.
The main changes observed in IP3R TKO HEK293 cells
were a reduced growth rate, reduced oxygen consumption, and
an increased basal rate of autophagy with no changes in
glucose or glutamine consumption. Some of these observations are in agreement with previous studies. A lower rate of
proliferation and migration in IP3R TKO HEK293 cells has
been reported recently (31). A reduced baseline and FCCPstimulated oxygen consumption was observed in Seahorse
assays (85). Acute inhibition or chronic loss of IP3Rs promotes
an increase in basal autophagy in several cell types, but
different mechanisms for this effect have been proposed
(86, 87). In our studies, it is clear that the effects are independent of AMPK activation. Only minor changes in metabolic rewiring could be observed in the 13C-tracer studies,
including an increase in anaplerosis of glucose carbon through
PC, and an increase in RC of glutamine and palmitate syntheses. All these effects were signiﬁcantly smaller than
observed with MCU KO cells (Figs. 5 and 6). Overall, the data
show that the loss of mitochondrial Ca2+ signaling induced by
the stable KO of IP3Rs or MCU produce quite distinct phenotypes. We cannot exclude the possibility that some of the
changes seen in MCU KO cells may result from the loss of a
scaffolding role of the MCU protein itself, rather than the lack
of mitochondrial Ca2+ ﬂuxes. Further investigation of the
protein–protein interactions of MCU in the mitochondrial
matrix and the role of these complexes in regulating the
structure/function of mitochondria are required to test this
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possibility. Electron microscopy images of MCU KO HEK293T
cells provided no indication of differences in gross mitochondrial structure or ER/mitochondrial distances (not
shown). Both HEK293T and HeLa cells show a decreased
agonist-mediated cytosolic Ca2+ response in the MCU KO
cells (Figs. 1, A and H, and 7C). However, an increased agonistmediated Ca2+ transient has been reported in other MCU KO
models including MEFs (47) and vascular smooth muscle cells
(46), where the result has been attributed to a lack of mitochondrial Ca2+ buffering. The intracellular store Ca2+ content
or the dynamics of IP3-mediated Ca2+ puffs were not altered in
MCU KO HEK293 cells (69). Thus, mechanisms acting upstream of IP3 synthesis/degradation, or affecting Ca2+ extrusion from the cytosol via plasma membrane or ER Ca2+
pumps, are more likely to be involved. Increased rates of both
ER and plasma membrane Ca2+ pumping have been reported
in several MCU KO cell types (69). Further studies are
required to establish a deﬁnitive mechanism for the decreased
cytosolic Ca2+ signaling observed in our MCU KO cells.
A hypothesis that has gained general acceptance is that the
baseline bioenergetic needs of both normal and cancer cells
requires constitutive ER-to-mitochondrial Ca2+ translocation
in order to stimulate mitochondrial Ca2+-dependent dehydrogenases of the TCA cycle (27, 28). It is argued that
cancer cells are particularly “addicted” to this process, which,
if interrupted, limits ATP supply for cell division and results
in cell death (27–29). The main evidence for this hypothesis
has been acquired primarily after acute treatment with the
drug Xestospongin-B (which targets the IP3R) and siRNA
silencing of MCU or IP3R (27, 28). Our experimental conditions differ because we have examined the long-term effects
of MCU and IP3R gene disruption. The studies show that
these cells have adapted to maintain their ATP levels, with no
requirement for basal mitochondrial or cytosolic Ca2+
signaling. This suggests that glycolysis has adequate excess
capacity to maintain ATP requirements and that sufﬁcient
mitochondrial Ca2+ is present to operate the TCA cycle and
supply biosynthetic precursors. This appears to be true even
when glycolysis and glutamine metabolism are accelerated to
accommodate the increased growth rate of MCU KO cells.
However, differences in behavior are revealed when the cells
are switched from glucose to galactose so that they predominantly rely on the TCA cycle for both energy and
biosynthetic precursors. Under these conditions, the MCU
KO cells show evidence of bioenergetic failure with ATP loss,
AMP accumulation, and cell death (Fig. 9). This phenotype is
suppressed in the MCU-rescue cells. Surprisingly, the IP3R
TKO cells are unaffected by the galactose switch, again
underscoring that basal metabolism is relatively insensitive to
Ca2+ in these cells. A cell death assay using a 24 h period of
incubation of K562 leukemic cells in galactose has been used
to screen for genes involved in oxidative phosphorylation
(88). Further studies are needed to determine if the behavior
of the MCU KO cells in galactose medium simply reﬂects the
inability to meet ATP demand (e.g., for mitosis), or if there
are secondary defects in the oxidative phosphorylation
machinery.

Calcium is viewed as a universal second messenger regulating a wide variety of biological processes (1). Global and
conditional mouse KOs of IP3R isoforms have supported a
biologically important role for intracellular Ca2+ signals (15).
Yet, it is also apparent that several cancer cells (e.g., HEK293,
HeLa, and DT40 lymphocytes) can survive the loss of all three
IP3R isoforms. Several evolutionary lineages either lack
recognizable IP3Rs (89, 90) or have independently lost IP3Rs
while retaining MCU homologs (91, 92). Thus, the phenotype
of cells without Ca2+ signaling may utilize ancestral Ca2+-independent signaling mechanisms and/or additional transcriptional rewiring resulting from disruption of IP3R genes. Future
RNA-Seq studies could provide useful information on the
molecular mechanisms underlying the adaptive responses of
growth and metabolism seen after loss of IP3Rs and MCU.
Targeting Ca2+ signaling with drugs that block ER–
mitochondrial communication is being explored as a strategy
for the treatment of various diseases where there is aberrant
translocation of Ca2+ into the mitochondria (93–95). Chronic
use of these drugs may induce metabolic and bioenergetic
adaptations similar to those seen in the present study. Understanding these mechanisms would aid in optimizing the
therapeutic beneﬁts of blocking Ca2+ signaling in disease
states.

Experimental procedures
Cell lines and culture
All cells were cultured at 37  C and 5% CO2 in DMEM
supplemented with 5% fetal bovine serum, 1% penicillin/
streptomycin, and 0.25 μg/ml amphotericin B. HEK293 IP3R
TKO cells and HeLa IP3R TKO cells were made as described
previously (30, 32). Most of the experiments in this study used
HEK293T MCU KO cells made by TALEN knockdown that
were obtained from the laboratory of Dr Vamsi Mootha (48).
The appropriate controls for the IP3R TKO and MCU KO cells
are WT HEK293 cells and HEK293T cells, respectively. We
have compared several parameters investigated in the present
study and did not ﬁnd them to be signiﬁcantly different in the
controls (Figs. 1A and 2A and S1). Therefore, the main ﬁgures
show only the WT HEK293 cells as the controls for both IP3R
TKO and MCU KO cells.
Ca2+ measurements
Trypsin-released cells were seeded on a black, clear-bottom,
and 96-well plate at a density of 5 × 105 cells/well and incubated at 37  C and 5% CO2 for 24 h. Media were aspirated
from all wells of the plate and replaced with 190 μl of Ca2+assay buffer (Hank’s balanced salt solution containing MgCl2
[1 mM], CaCl2 [2.3 mM], and 20 mM Hepes [pH 7.2]) supplemented with 5 μM Fluo8-AM, 500 μM Brilliant Black, and
100 μM sulﬁnpyrazone. The plate was maintained in the
incubator for 45 min. Changes in cytosolic Ca2+ were monitored using a FlexStation II plate reader in ﬂuorescence mode
at 37  C. Measurements were made using excitation and
emission wavelengths of 485 and 525 nm, respectively. The
additions of Cch, FCCP, oligomycin, and ionomycin were
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made by utilizing the automated ﬂuidics system of the hardware. In some experiments, cells were loaded as aforementioned with 1 μM Fura2-AM, and Ca2+ was measured
ratiometrically using excitation and emission wavelengths of
340/380 and 510 nm, respectively. Ca2+ ﬂuxes in permeabilized
cells were measured after harvesting cells grown in 100 mm
plates with trypsin. The cells were centrifuged (1000g;
2 min),washed in Ca2+/Mg2+-free Hank’s balanced salt solution and then resuspended in 600 μl of dye buffer (2 μM Fluo5N, 120 mM KCl, 1 mM MgCl2, 25 mM Hepes [pH 7.2], 5 mM
succinate, 2 mM TrisPi, 4 μM rotenone, and 1 μM thapsigargin), and permeabilized using saponin (10 μg). Permeabilization was veriﬁed by trypan blue staining. Aliquots
(90 μl) were transferred to wells of a black transparent bottom
96-well plate. The plate was maintained at 37  C, and measurements were made using excitation and emission wavelengths of 491 and 516 nm, respectively.
For imaging experiments, cells were preincubated in a
serum-free extracellular medium (121 mM NaCl, 5 mM
NaHCO3, 10 mM Na–Hepes, 4.7 mM KCl, 1.2 mM KH2PO4,
1.2 mM MgSO4, 2 mM CaCl2, and 10 mM glucose [pH 7.4])
containing 2% bovine serum albumin (BSA). For measurements of [Ca2+]c, cells were loaded with 2 μM Cal520-AM
(AAT Bioquest) together with 0.003% pluronic F127 and
100 μM sulﬁnpyrazone for 30 min at 30  C. At the end of the
preincubation or dye-loading period, the cells were washed
into fresh extracellular medium containing 0.25% BSA and
transferred to the temperature-regulated stage (37  C) of the
microscope. Fluorescence wide-ﬁeld imaging of [Ca2+]c, and
[Ca2+]m was carried out using a back-illuminated electron
multiplying charge-coupled device camera (Photometrics).
GEM-GECO was excited with 403/10 nm, whereas emission
pairs were monitored using 435/30 nm (Ca2+-free) and 550/
30 nm (Ca2+-bound) emission ﬁlters. Cal520 was imaged using
490/10 nm excitation ﬁlters and a 550 nm long-pass beam
splitter, and an image triplet was obtained every 250 ms to
maximize kinetic information. Fluorescence is presented as F/
F0 or GEM-GECO emission ratios, calculated following
background subtraction of the individual wavelengths.
Growth curves
About 2.5 × 105 HEK293, HEK293T, or HeLa cell lines were
plated on 100 mm plates. At the indicated times, plates were
trypsinized for 4 min and resuspended in 10 ml DMEM. The
cell density was counted in triplicate using a hemocytometer.
Metabolite assays
Glucose consumption was measured after a 1 h period in
which the cells were incubated in glucose-free medium. About
5 mM glucose was then added, and aliquots of the media (250
μl) were removed for glucose assay at the indicated times. A
previously described colorimetric method using glucose oxidase was modiﬁed for use on a plate reader as described (96).
Lactate was measured in neutralized perchloric acid (PCA)
lysates using LDH as previously described (97). Pyruvate was
measured with pyruvate oxidase and Amplex red (98).
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Nicotinamide nucleotides were measured using enzymatic
cycling assays. Cells grown on 10 cm2 plates were released with
0.25% trypsin/EDTA and centrifuged (1000g; 5 min). The
pellets were resuspended in 1 ml PBS, split into two equal
aliquots, and recentrifuged. For NAD+/NADP+ assay, the cell
pellet was resuspended with 100 μl 0.6 M PCA. For NADH/
NADPH assay, the cell pellet was resuspended in 100 μl of 1 M
KOH, heated at 65  C for 30 min, and brieﬂy sonicated (10 s).
All samples were stored at −80  C prior to assay. NAD+ and
NADH were measured by an enzymatic cycling assay using
alcohol dehydrogenase (99). NADP+ and NADPH were
measured by an enzymatic cycling assay using glucose-6phosphate dehydrogenase (100). ATP was assayed in neutralized PCA extracts using a luciferase method (101). AMP was
assayed using the AMP-glo kit (Promega) following the manufacturer’s instructions.
SDS-PAGE/Western blotting
To prepare lysates, cells incubated in DMEM were washed
in PBS and lysed in a medium (0.250 ml) containing 1%
Triton X-100, 50 mM Tris–HCl (pH 7.8), 150 mM NaCl,
2 mM sodium orthovanadate, 10 mM sodium pyrophosphate,
20 mM NaF, and a 1× dilution of a complete protease inhibitor mixture (Roche Diagnostics). The lysates were
centrifuged at 12,000g for 10 min. The supernatants were
denatured in SDS sample buffer. Lysates were boiled at 100

C for 5 min and then stored at −20  C until use. Unless
otherwise noted, 40 μg of protein were run at 100 V for
90 min on 10% polyacrylamide gels and transferred at 100 V
for 60 min onto nitrocellulose membranes. Polyvinylidene
diﬂuoride membranes were used in the speciﬁc case of LC3
immunoblotting. Membranes were blocked in Tris-buffered
saline with Tween-10 supplemented with 5% BSA for 1 h at
room temperature. Following 3 × 15 min washes in Trisbuffered saline with Tween-10, the primary antibody was
added for 16 h at 4  C. All the antibodies were used at a
dilution of 1:1000 and were obtained from Cell Signaling.
Membranes were developed using ECL reagent (Thermo
Fisher Scientiﬁc). When necessary, membranes were stripped
using a buffer containing SDS (2%; w/v), Tris (62.5 mM; pH
6.8), and β-mercaptoethanol (100 mM).
Oxygen consumption
Cells were seeded at a density of 2 × 105 and were grown on
60 mm plates for 5 days. Trypsinized cells (106) resuspended in
DMEM were introduced into the chamber of an O2 electrode
(Oroboros Instruments GmbH). Baseline rates of O2 consumption and the rates after sequential addition of 5 μM oligomycin, 10 μM FCCP, and 1 μM antimycin A were measured.
Labeled isotope tracing
Cells were seeded on 60 mm plates with 2 × 105 cells in
DMEM and grown for 5 days. To label with glutamine, the
DMEM, containing all other components except glutamine,
was supplemented with 4 mM L-[U–13C] glutamine. The
plates were labeled in triplicate with 1 ml of medium for
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30 and 60 min. To label with glucose, the DMEM, containing
all other components except glucose, was supplemented with
5 mM D-[U–13C] glucose. The plates were labeled in triplicate
with 1 ml medium for 5 and 60 min. At the indicated times,
the plates were aspirated and rapidly washed in ice-cold PBS.
Metabolites were extracted by rocking in 0.5 ml buffer containing 5:3:2 ratios of methanol, acetonitrile, and water for
10 min at 4  C. The solvent was removed, centrifuged at
12,000g for 10 min, and stored at −80  C prior to analysis.
LC–MS analysis was performed on a Q Exactive
HybridQuadrupole-Orbitrap HF-X MS (Thermo Fisher Scientiﬁc) equipped with a HESI II probe and coupled to a
Vanquish Horizon UHPLC system (Thermo Fisher Scientiﬁc).
Conditions for chromatography, mass spectroscopy, identiﬁcation, and quantitation of metabolites were as detailed in the
study by Casciano et al. (102).
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CRISPR–Cas9 MCU KO and rescue
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MCU KO clones of HeLa cells were obtained using Cas9/
guide RNA ribonucleoprotein complexes (103). Two CRISPR
RNA sequences were used: GAUCGCUUCCUGGCAGAA
UUGUUUUAGAGCUAUGCU; UGAACUGACAGCGUUCA
CGCGUUUUAGAGCUAUGCU. Guide RNA complexes were
formed by annealing the CRISPR RNA with transactivating
RNA as described by Jacobi et al. (104). The complexes were
combined with recombinant Cas9 nuclease and transfected
into HeLa cells with Lipofectamine 3000. RNAs and Cas9 were
purchased from Integrated DNA Technologies. After 1 week
of growth, the cells were subcloned by limiting dilution into
96-well plates. Individual clones were expanded into 35 mm
plates and screened for MCU expression by immunoblotting.
MCU rescue in MCU KO HEK293T cells was carried out by
transfecting a plasmid encoding a C-terminal FLAG-tagged
human MCU (Addgene; catalog no.: 50054) using Lipofectamine 3000 and selecting for stable transfectants using
hygromycin (20 μg/ml).
Data collection and analysis
Unless otherwise noted, the data are expressed as means ±
SEM of three independent experiments, each performed in
technical triplicate. GraphPad Prism (GraphPad Software, Inc)
was used to generate plots and perform statistical analysis. A
complete list of statistical analysis of the ﬁgures can be found
in Table S1.
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